Related Experiment Video
Updated: Apr 28, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes
Kaiyin Wu1, Klemens Budde, Huber Lu
11 Medizinische Klinik mit Schwerpunkt Nephrologie, Charité Campus Mitte, Universitätsmedizin Berlin, Germany. 2 Institut für Pathologie, Charité Campus Mitte, Universitätsmedizin Berlin, Germany. 3 Address correspondence to: Dr. Birgit Rudolph, Institut für Pathologie, Charite Campus Mitte, Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Insights
Acute cellular rejection (ACR) severity and timing impact kidney transplant graft survival. Vascular or late ACR predicts poorer outcomes, while tubulointerstitial inflammation extent is not significant for vascular rejection prognosis.
Area of Science:
- Nephrology
- Transplant Immunology
- Pathology
Background:
- The association between acute cellular rejection (ACR) severity and timing, as defined by the 2009 Banff classification, and long-term graft survival remains unclear.
- Understanding these factors is crucial for optimizing post-transplant management and improving patient outcomes.
Purpose of the Study:
- To investigate the impact of ACR severity and timing on death-censored graft survival (DCGS) in kidney transplant recipients.
- To identify specific histological features associated with poor graft survival.
Main Methods:
- ACR severity was categorized into low (borderline), moderate (TCMR I - interstitial rejection), and high (TCMR II/III - vascular rejection).
- Biopsies negative for donor-specific antibodies (DSA), C4d, and microcirculation changes were analyzed.
- Early (≤6 months) and late (>6 months) ACR were defined, with a control group of patients without post-transplant biopsy.
Main Results:
- All ACR groups showed significantly lower DCGS rates compared to controls (P<0.001).
- Late ACR was associated with significantly poorer graft survival than early ACR (63.6% vs. 87.4%, P<0.001).
- Intimal arteritis (Banff v-lesion) was an independent predictor of long-term graft loss, irrespective of ACR timing.
Conclusions:
- All forms of ACR negatively affect long-term kidney transplant graft survival.
- Vascular rejection and late-occurring ACR are particularly detrimental to graft survival.
- The degree of tubulointerstitial inflammation does not significantly influence prognosis in vascular rejection.
Background:
It is unclear if the severity or the timing of acute cellular rejection (ACR) defined by Banff classification 2009 is associated with graft survival.
Methods:
Borderline changes, TCMR I (interstitial rejection), and TCMR II/III (vascular rejection) were defined as low, moderate, and high ACR severity, respectively. Approximately 270 patients who had at least one episode of ACR were enrolled, 270 biopsies were chosen which showed the highest ACR severity of each patient and were negative for donor-specific antibodies (DSA), C4d, and microcirculation changes (MC). Six months were used as the cutoff to define early and late ACR; 370 patients without biopsy posttransplantation were recruited in the control group.
Results:
Up to 8-year posttransplantation, death-censored graft survival (DCGS) rates of control, borderline, TCMR I, and TCMR II/III groups were 97.6%, 93.3%, 79.6%, and 73.6% (log rank test, P<0.001); the control group had significantly higher DCGS rate than the three ACR groups (each pairwise comparison yields P<0.05). The DCGS rate of late ACR was significantly lower compared with early ACR (63.6% vs. 87.4%, P<0.001). Intimal arteritis (Banff v-lesion) was an independent histologic risk factor correlated with long-term graft loss regardless of the timing of ACR. The v-lesions with minimal or high-grade tubulitis displayed similar graft survival (72.7% vs. 72.9%, P=0.96).
Conclusion:
All types of ACR affect long-term graft survival. Vascular or late ACR predict poorer graft survival; the extent of tubulointerstitial inflammation (TI) is of no prognostic significance for vascular rejection.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury I: Introduction
Kidney Transplant I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Kidney Transplant III: Nursing Management

